MA

908 Devices Inc.NASDAQ MASS Stock Report

Last reporting period 30 Jun, 2024

Updated 15 Nov, 2024

Last price

Market cap $B

0.126

Micro

Exchange

XNAS - Nasdaq

MASS Stock Analysis

MA

Uncovered

908 Devices Inc. is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

13/100

Low score

Market cap $B

0.126

Dividend yield

Shares outstanding

32.047 B

908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Boston, Massachusetts. The company went IPO on 2020-12-18. The firm's Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908 and Rebel. MX908 is a handheld Mass Spec device designed for analysis of gas, liquid and solid materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a desktop analyzer providing real-time information on the extracellular environment in bioprocesses.

View Section: Eyestock Rating